1. Introduction

1.1          Study Scope

1.2          The Insight Partners Research Report Guidance

1.3          Market Segmentation

1.3.1          US Compounding Pharmacies Market – By Product

1.3.2          US Compounding Pharmacies Market – By Therapeutic Area

2. Key Takeaways

3. Research Methodology

3.1          Coverage

3.2          Secondary Research

3.3          Primary Research

4. US Compounding Pharmacies Market Landscape

4.1          Market Overview

4.2          PEST Analysis

4.2.1          US: PEST Analysis

4.3          Expert Opinion

5. US Compounding Pharmacies Market – Key Market Dynamics

5.1          Market Drivers

5.1.1          Drug Shortage Crisis in US

5.1.2          Benefits Associated with Compounded Medications

5.2          Market Restraints

5.2.1          Product Recalls and Stringent Regulatory Requirements

5.3          Market Opportunities

5.3.1          Growing Demand for Compounding Pharmacy During COVID-19

5.4          Future Trends

5.4.1          Growing Outsourcing Facilities for Manufacturing and Sales of Products

5.5          Impact Analysis

6. Compounding Pharmacies– US Market Analysis

6.1          US Compounding Pharmacies Market Overview

6.2          Market Positioning of Key Players

7. US Compounding Pharmacies Market Analysis– Product

7.1          Overview

7.2          US Compounding Pharmacies Market, by Product 2019 & 2027 (%)

7.3          Oral Medications

7.3.1          Overview

7.3.2          US Oral Medications Market Revenue and Forecasts to 2027 (US$ Mn)

7.4          Topical Medications

7.4.1          Overview

7.4.2          US Topical Medications Market Revenue and Forecasts to 2027 (US$ Mn)

7.5          Suppositories

7.5.1          Overview

7.5.2          US Suppositories Market Revenue and Forecasts to 2027 (US$ Mn)

7.6          Others

7.6.1          Overview

7.6.2          Others Market Revenue and Forecasts to 2027 (US$ Mn)

8. US Compounding Pharmacies Market Analysis – Therapeutic Area

8.1          Overview

8.2          US Compounding Pharmacies Market, By Therapeutic Area 2019 & 2027 (%)

8.3          Pain Medications

8.3.1          Overview

8.3.2          US Pain Medications Market Revenue and Forecasts to 2027 (US$ Mn)

8.4          Hormone Replacement Therapies

8.4.1          Overview

8.4.2          US Hormone Replacement Therapies Market Revenue and Forecasts to 2027 (US$ Mn)

8.5          Dermatological Applications

8.5.1          Overview

8.5.2          US Dermatological Applications Market Revenue and Forecasts to 2027 (US$ Mn)

8.6          Others

8.6.1          Overview

8.6.2          US Others Market Revenue and Forecasts to 2027 (US$ Mn)

9. Impact of COVID-19 Pandemic on US Compounding Pharmacies Market

9.1          US: Impact Assessment of COVID-19 Pandemic

10. Industry Landscape

10.1        Overview

10.2        Growth Strategies Done by the Companies in the Market, (%)

10.3        Organic Developments

10.3.1        Overview

10.4        Inorganic Developments

10.4.1        Overview

11. Company Profiles

11.1        Fagron, Inc.

11.1.1        Key Facts

11.1.2        Business Description

11.1.3        Products and Services

11.1.4        Financial Overview

11.1.5        SWOT Analysis

11.1.6        Key Developments

11.2        Triangle Compounding Pharmacy

11.2.1        Key Facts

11.2.2        Business Description

11.2.3        Products and Services

11.2.4        Financial Overview

11.2.5        SWOT Analysis

11.2.6        Key Developments

11.3        Institutional Pharmacy Solutions, LLC

11.3.1        Key Facts

11.3.2        Business Description

11.3.3        Products and Services

11.3.4        Financial Overview

11.3.5        SWOT Analysis

11.3.6        Key Developments

11.4        B.Braun Melsungen AG

11.4.1        Key Facts

11.4.2        Business Description

11.4.3        Products and Services

11.4.4        Financial Overview

11.4.5        SWOT Analysis

11.4.6        Key Developments

11.5        PharMEDium Healthcare Holdings, Inc.

11.5.1        Key Facts

11.5.2        Business Description

11.5.3        Products and Services

11.5.4        Financial Overview

11.5.5        SWOT Analysis

11.5.6        Key Developments

11.6        Fresenius Kabi AG

11.6.1        Key Facts

11.6.2        Business Description

11.6.3        Products and Services

11.6.4        Financial Overview

11.6.5        SWOT Analysis

11.6.6        Key Developments

11.7        Avella specialty pharmacy

11.7.1        Key Facts

11.7.2        Business Description

11.7.3        Products and Services

11.7.4        Financial Overview

11.7.5        SWOT Analysis

11.7.6        Key Developments

11.8        Pencol Compounding Pharmacy

11.8.1        Key Facts

11.8.2        Business Description

11.8.3        Products and Services

11.8.4        Financial Overview

11.8.5        SWOT Analysis

11.8.6        Key Developments

11.9        Vertisis Custom Pharmacy

11.9.1        Key Facts

11.9.2        Business Description

11.9.3        Products and Services

11.9.4        Financial Overview

11.9.5        SWOT Analysis

11.9.6        Key Developments

1.44        US Compounding Inc.

1.44.1        Key Facts

1.44.2        Business Description

1.44.3        Products and Services

1.44.4        Financial Overview

1.44.5        SWOT Analysis

1.44.6        Key Developments

12. Appendix

12.1        About The Insight Partners

12.2        Glossary of Terms

LIST OF TABLES

Table 1.              A few drugs that are in short supply are listed below:

Table 2.              Organic Developments Done By Companies

Table 3.              Inorganic Developments Done By Companies

Table 4.              Glossary of Terms, US Compound Pharmacies Market

LIST OF FIGURES

Figure 1.            US Compounding Pharmacies Market Segmentation

Figure 2.            US Compounding Pharmacies Market Overview

Figure 3.            Topical Medication is Expected to Show Remarkable Growth During Forecast Period

Figure 4.            US Compounding Pharmacies Market, Industry Landscape

Figure 5.            US: PEST Analysis

Figure 6.            Expert Opinion

Figure 7.            US Compounding Pharmacies Market Impact Analysis of Drivers and Restraints

Figure 8.            Overview of US Compounding Pharmacies Market

Figure 9.            Market Positioning Of Key Players In US Compounding Pharmacies Market

Figure 10.          US Compounding Pharmacies Market, By Product 2019 & 2027 (%)

Figure 11.          US Oral Medications Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 12.          US Topical Medications Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 13.          US Suppositories Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 14.          US Others Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 15.          US Compounding Pharmacies Market, by Therapeutic Area 2019 & 2027 (%)

Figure 16.          US Pain Medications Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 17.          US Hormone Replacement Therapies Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 18.          US Dermatological Applications Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 19.          US Others Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 20.          Impact of COVID-19 Pandemic on Compounding Pharmacies Market in the US

Figure 21.          Growth Strategies Done by the Companies in the Market, (%)